市場調査レポート
商品コード
1389643

マラリア治療市場規模・予測、世界および地域別シェア、動向、成長機会分析レポート対象範囲:治療薬別、投与経路別、流通チャネル別

Malaria Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment, Route of Administration, and Distribution Channel

出版日: | 発行: The Insight Partners | ページ情報: 英文 320 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
マラリア治療市場規模・予測、世界および地域別シェア、動向、成長機会分析レポート対象範囲:治療薬別、投与経路別、流通チャネル別
出版日: 2023年11月02日
発行: The Insight Partners
ページ情報: 英文 320 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マラリア治療市場は、2022年の32億9,600万米ドルから2030年には244億8,700万米ドルに成長すると予測され、2022年から2030年までのCAGRは28.5%と推定されます。マラリア治療市場は、低所得国におけるマラリアの高い流行率や、国際機関や国家機関が開始した世界のマラリア撲滅プログラムによって拡大しています。また、先進的な診断ツールの発売数の増加や、効果的な治療薬を提供するための研究活動の活発化も、市場の成長をさらに後押ししています。しかし、偽造抗マラリア薬やその後の薬剤耐性といった要因が市場の成長を抑制しています。

世界保健機関(WHO)の最新の世界マラリア報告(WMR)2020によると、2019年に記録された2億2,700万症例に対し、世界では2億4,100万症例が報告されました。同報告書によると、マラリアによる死亡者数は年間6万9000人増加しています。これらの死者の約3分の2、すなわち4万7,000人は、COVID-19の大流行時のヘルスケアサービスの混乱が原因であり、残りの3分の1、すなわち2万2,000人は、WHOのマラリア死亡率算出手法の最近の変更(COVID-19の混乱とは無関係)を反映したものです。

WHOアフリカ地域は、マラリアの世界的負担の高い割合を占めています。2020年には、世界の患者数の約95%、死亡者数の約96%がアフリカでマラリアにより報告され、報告された死亡者数全体の約80%が5歳以下の小児でした。WHOによると、ナイジェリア、タンザニア、コンゴ民主共和国、モザンビークのアフリカ4カ国は、世界で報告されたマラリア関連死の約半数を記録しました。LANCET Regional Health 2020によると、アフリカ諸国はマラリアの負担が最も大きく、P. falciparumは5歳未満の小児の死亡率が最も高い顕著な原因であり、全世界で約77%を占めています。アフリカ諸国では、P. falciparumがマラリアによる小児の死亡者全体の約96%を占めています。P.vivaxは、主にアジアで発生したマラリア患者全体の2%(450万人)の原因となっています。WMR2021によると、世界のマラリア患者数の約2%は東南アジア諸国が占めており、2020年にはマラリア推定患者数の83%、マラリアによる死亡者数の82%をインドが占めています。このように、世界中のさまざまな地域でマラリアの有病率が上昇していることが、マラリア治療市場の成長を後押ししています。

マラリアの有病率が高い世界中のさまざまな国の政府は、治療オプションを含むヘルスケアサービスへのアクセスを改善することによって、この病気を根絶するためにさまざまな戦略を展開しています。その一部を以下に紹介する:

ミャンマーには、世界基金が承認した国家マラリア対策計画があり、2030年までにマラリア原虫による病気を撲滅することが期待されています。同国の国民皆保険制度には、顕微鏡検査や迅速診断検査(RDT)によるマラリア診断、アルテミシニンを主成分とする混合療法(ACT)へのアクセスも含まれています。

タイ政府は、国家マラリア撲滅戦略(NMES)2017-2026を実施し、2024年までにマラリア撲滅を目指す統合的撲滅戦略をさらに適用しています。

2020年1月、アフリカのマラリアに関する企業同盟(CAMA)は、マラリア制圧介入を通じて数百万人にマラリアを届け、それによってアフリカでの予防活動を拡大することを目的とした、2021~2023年の戦略計画を開始しました。

このように、マラリア病に対する認識を広めるための上記のイニシアチブは、マラリア治療市場の成長を後押しする撲滅活動を強化するものです。

マラリア治療市場を以下のように区分しています:

治療法に基づき、マラリア治療市場はジェネリック医薬品、オリジネーター、ワクチン、その他に区分されます。投与経路に基づき、マラリア治療市場は経口剤と非経口剤に区分されます。流通チャネル別では、マラリア治療市場は直接販売、病院薬局、小売薬局、オンライン薬局、その他に区分されます。地域別では、マラリア治療市場は北米(米国、カナダ、メキシコ)、欧州(英国、ドイツ、フランス、イタリア、スペイン、その他欧州地域)、アジア太平洋(中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域)に区分される、中東・アフリカ(サウジアラビア、UAE、南アフリカ、ケニア、タンザニア、ルワンダ、ナイジェリア、ガーナ、ウガンダ、アンゴラ、カメルーン、セネガル、ザンビア、その他中東・アフリカ)、中南米(ブラジル、アルゼンチン、その他南米)。

治療に基づく洞察

マラリア治療市場は、治療法に基づき、ジェネリック医薬品、オリジネーター、ワクチン、その他に区分されます。ワクチン分野が2022年に最大の市場シェアを占めました。ワクチンは、特定の感染症に対する能動的な獲得免疫を提供します。マラリアワクチン市場は、研究開発活動の活発化とワクチン候補のパイプラインの増加により、著しい成長率で成長しています。

投与経路に基づく洞察

投与経路に基づき、マラリア治療市場は経口薬と非経口薬・静脈注射薬に二分されます。2022年の市場シェアは経口剤が最大であったが、予測期間中は非経口剤が最も高いCAGRを記録する見込みです。経口ドラッグデリバリーは、高い患者コンプライアンス、非侵襲性、最小限の無菌制約、費用対効果、剤形設計の柔軟性、製造プロセスの容易さなどを提供するため、最も好まれ、適切な薬剤投与経路です。投与の容易さや長期的なコスト効率といった利点は、経口薬の採用を促進する主な要因です。

流通チャネルに基づく洞察

流通チャネルに基づき、マラリア治療市場は直接入札、病院薬局、小売薬局、オンライン薬局、その他に区分されます。2022年には、直接入札セグメントが市場で最大のシェアを占めたが、予測期間中はオンライン薬局セグメントが最も高いCAGRを記録すると予想されます。経口ドラッグデリバリーは、高い患者コンプライアンス、非侵襲性、最小限の無菌制約、費用対効果、剤形設計の柔軟性、製造プロセスの容易さなどを提供するため、最も好まれ、適切な薬剤投与経路です。投与の容易さや長期的なコスト効率といった利点は、経口薬の採用を後押しする大きな要因となっています。

マラリア治療市場に関する報告書作成にあたり参照した主な一次情報および二次情報は、世界保健機関(WHO)、米国国勢調査局、CDCなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察-マラリア

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 マラリア治療市場の情勢

  • PEST分析-マラリア治療

第5章 マラリア治療市場- 主要産業力学

  • 主な市場促進要因
    • マラリアの有病率の増加
    • マラリアに関する意識向上への取り組みの高まり
  • 市場抑制要因
    • 偽造抗マラリア薬の入手可能性とその後の薬剤耐性
  • 市場機会
    • 市場プレイヤーによる戦略的イニシアチブの高まり
  • 今後の動向
    • 新薬とワクチンのパイプラインの拡大
  • 影響分析

第6章 マラリア治療市場:世界市場分析

  • マラリア治療市場の収益、2022年~2030年
  • 地域分析市場の収益、2022年~2030年

第7章 マラリア治療市場- 2030年までの収益と予測:治療薬別

  • マラリア治療市場の収益シェア、治療薬別、2022年および2030年
  • ワクチン
  • ジェネリック医薬品
  • オリジネーター
  • その他

第8章 マラリア治療市場- 2030年までの収益と予測:投与経路別

  • マラリア治療市場の収益シェア、投与経路別、2022年および2030年
  • 経口剤
  • 非経口

第9章 マラリア治療市場- 2030年までの収益と予測:流通経路別

  • マラリア治療市場の収益シェア、流通経路別、2022年および2030年
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第10章 マラリア治療市場:地域別分析

  • 北米
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • その他欧州
  • アジア太平洋
    • その他アジア太平洋地域
  • 中東・アフリカ
    • その他中東とアフリカ
  • 中南米
    • その他中南米

第11章 マラリア治療市場の業界情勢

  • マラリア治療市場の成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Pfizer Inc
  • AdvaCare Pharma USA LLC
  • VLP Therapeutics LLC
  • Lupin Ltd

第13章 付録

第14章 付録

図表

List Of Tables

  • Table 1. Malaria Treatment Market Segmentation
  • Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
  • Table 3. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 4. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Retail Pharmacies
  • Table 5. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 6. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 7. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 8. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 9. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 10. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 11. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 12. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 13. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 14. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 15. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 16. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 17. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 18. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 19. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 20. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 21. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 22. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 23. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 24. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 25. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 26. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 27. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 28. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 29. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 30. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 31. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 32. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 33. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 34. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 35. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 36. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 37. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 38. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 39. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 40. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 41. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 42. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 43. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 44. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 45. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 46. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 47. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 48. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 49. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 50. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 51. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 52. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 53. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 54. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 55. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 56. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 57. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 58. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 60. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 61. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 62. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 63. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 64. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 65. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 66. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 67. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 69. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 71. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 72. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 73. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 74. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 75. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 76. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 77. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 78. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 79. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 80. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 81. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 82. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 83. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 84. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 85. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 86. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 87. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 88. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 89. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 90. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 91. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 92. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 93. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 94. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 95. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 96. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 97. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 98. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 99. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 100. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 101. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 102. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 103. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 104. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 105. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 106. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 107. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 108. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 109. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 110. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 111. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 112. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 113. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 114. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 115. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 116. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 117. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 118. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 119. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 120. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 121. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 122. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 123. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 124. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 125. Nigeria Malaria Treatment Market, by Treatment - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 127. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 128. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 129. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 130. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 131. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 132. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 133. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 134. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 135. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 136. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 137. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 138. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 139. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 140. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 141. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 142. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 143. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 144. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 145. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 146. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 147. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 148. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 149. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 150. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 151. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 152. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 153. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 154. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 155. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 156. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 157. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 158. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 159. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 160. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 161. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 162. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 163. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 164. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 165. South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 166. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Route of Administration
  • Table 167. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Distribution Channel
  • Table 168. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 169. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) - Hospital Pharmacies
  • Table 170. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 171. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 172. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 173. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 174. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 175. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment
  • Table 176. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Route of Administration
  • Table 177. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel
  • Table 178. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Hospital Pharmacies
  • Table 179. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Retail Pharmacies
  • Table 180. Recent Inorganic Growth Strategies in the Malaria Treatment Market
  • Table 181. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 182. Glossary of Terms, Malaria Treatment Market

List Of Figures

  • Figure 1. PEST Analysis - Malaria
  • Figure 2. Malaria Treatment Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Malaria Treatment Market Revenue (US$ million), 2020 - 2030
  • Figure 5. Malaria: Geography Analysis Market Revenue (US$ million), 2022 - 2030
  • Figure 6. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • Figure 7. Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 8. Generic Drugs Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 9. Originators Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 10. Others Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • Figure 12. Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 15. Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hospital Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 21. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 22. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 23. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
  • Figure 27. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 29. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Malaria Treatment Market, 2022 ($Mn)
  • Figure 36. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 38. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Malaria Treatment Market, 2022 (US$ Mn)
  • Figure 44. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 46. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Malaria Treatment Market, 2022 ($Mn)
  • Figure 61. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 63. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 65. Growth Strategies in the Malaria Treatment Market
目次
Product Code: TIPRE00018229

The malaria treatment market is expected to grow from US$ 3.296 billion in 2022 to US$ 24.487 billion by 2030; it is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000 deaths. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO's methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).

The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ~77% across the world; in African countries, P. falciparum accounts for ~96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ~2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associate with malaria in 2020. Thus, the rising prevalence of malaria in different regions across the globe boosts the malaria treatment market growth.

Governments of various countries across the globe with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to healthcare services, including treatment options, to the people. A few of the initiatives undertaken are as follows:

Myanmar has a national malaria control plan that the Global Fund has approved, and by 2030, it is expected to eliminate the disease caused by P. falciparum. The universal healthcare coverage in the country also includes access to malaria diagnosis by means of microscopy or rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs).

The government of Thailand has implemented a National Malaria Elimination Strategy (NMES) 2017-2026 that further applies an integrated elimination strategy that aims to eradicate the disease by 2024.

In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023 with an aim to reach millions of people through malaria control interventions and thereby scale up prevention activities in Africa.

Thus, the abovementioned initiatives to spread awareness about malaria disease reinforce the eradication efforts to bolster the malaria treatment market growth.

The report segments the malaria treatment market as follows:

Based on treatment, the malaria treatment market is segmented into generic drugs, originators, vaccines, and others. Based on route of administration, the malaria treatment market is divided into oral and parenteral. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. By geography, the malaria treatment market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, Kenya, Tanzania, Rwanda, Nigeria, Ghana, Uganda, Angola, Cameroon, Senegal, Zambia, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into generic drugs, originators, vaccines, and others. vaccines segment held the largest market share in 2022. Vaccines provide active acquired immunity against particular infectious disease. The market for malaria vaccines is growing at a significant growth rate owing to increasing research and development activities and increasing pipeline of vaccine candidates.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2022; however, the parenteral segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2022; however, the online pharmacies segment is expected to register the highest CAGR during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs.

A few of the major primary and secondary sources referred to while preparing the report on the malaria treatment market are the World Health Organization (WHO), the US Census Bureau, and CDC, among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights - Malaria

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Malaria Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis - Malaria Treatment

5. Malaria Treatment Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Prevalence of Malaria
    • 5.1.2 Rising Initiatives to Raise Awareness about Malaria
  • 5.2 Market Restraints
    • 5.2.1 Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Market Players
  • 5.4 Future Trends
    • 5.4.1 Extending Pipeline of New Drugs and Vaccines
  • 5.5 Impact Analysis

6. Malaria Treatment Market - Global Market Analysis

  • 6.1 Malaria Treatment Market Revenue (US$ million), 2022 - 2030
  • 6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Malaria Treatment Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
  • 7.3 Vaccines
    • 7.3.1 Overview
    • 7.3.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Generic Drugs
    • 7.4.1 Overview
    • 7.4.2 Generic Drugs Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Originators
    • 7.5.1 Overview
    • 7.5.2 Originators Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Malaria Treatment Market - Revenue and Forecast to 2030 - by Route of Administration

  • 8.1 Overview
  • 8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
  • 8.3 Oral
    • 8.3.1 Overview
    • 8.3.2 Oral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Parenteral
    • 8.4.1 Overview
    • 8.4.2 Parenteral: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Malaria Treatment Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Direct Tender
    • 9.3.1 Overview
    • 9.3.2 Direct Tender: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Hospital Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Hospital Pharmacies: Malaria Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.4.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
  • 9.5 Retail Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Retail Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.5.2.1.1 Malaria Treatment Market, by Retail Pharmacies
  • 9.6 Online Pharmacies
    • 9.6.1 Overview
    • 9.6.2 Online Pharmacies: Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others : Malaria Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Malaria Treatment Market - Geographical Analysis

  • 10.1 North America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.1 North America: Malaria Treatment Market, by Treatment
      • 10.1.2.2 North America: Malaria Treatment Market, by Route of Administration
      • 10.1.2.3 North America: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.3.1 North America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.3.2 North America: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.4 North America: Malaria Treatment Market, by Country
      • 10.1.2.5 US
      • 10.1.2.6 Overview
        • 10.1.2.6.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 US: Malaria Treatment Market, by Treatment
        • 10.1.2.6.3 US: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.6.4 US: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.6.4.1 US: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.6.4.2 US: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.7 Canada
      • 10.1.2.8 Overview
        • 10.1.2.8.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.2 Canada: Malaria Treatment Market, by Treatment
        • 10.1.2.8.3 Canada: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.8.4 Canada: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.8.4.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.8.4.2 Canada: Malaria Treatment Market, by Retail Pharmacies
      • 10.1.2.9 Mexico
      • 10.1.2.10 Overview
        • 10.1.2.10.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.2 Mexico: Malaria Treatment Market, by Treatment
        • 10.1.2.10.3 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.1.2.10.4 Mexico: Malaria Treatment Market, by Distribution Channel
        • 10.1.2.10.4.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
        • 10.1.2.10.4.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
  • 10.2 Europe Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.2.1 Overview
    • 10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.2.2.1 Europe: Malaria Treatment Market, by Treatment
      • 10.2.2.2 Europe: Malaria Treatment Market, by Route of Administration
      • 10.2.2.3 Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.3.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.3.2 Europe: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.4 Europe: Malaria Treatment Market, by Countries
      • 10.2.2.5 France
      • 10.2.2.6 Overview
        • 10.2.2.6.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.6.2 France: Malaria Treatment Market, by Treatment
        • 10.2.2.6.3 France: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.6.4 France: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.6.4.1 France: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.6.4.2 France: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.7 UK
      • 10.2.2.8 Overview
        • 10.2.2.8.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.8.2 UK: Malaria Treatment Market, by Treatment
        • 10.2.2.8.3 UK: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.8.4 UK: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.8.4.1 UK: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.8.4.2 UK: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.9 Italy
      • 10.2.2.10 Overview
        • 10.2.2.10.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.10.2 Italy: Malaria Treatment Market, by Treatment
        • 10.2.2.10.3 Italy: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.10.4 Italy: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.10.4.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.10.4.2 Italy: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.11 Germany
      • 10.2.2.12 Overview
        • 10.2.2.12.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.12.2 Germany: Malaria Treatment Market, by Treatment
        • 10.2.2.12.3 Germany: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.12.4 Germany: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.12.4.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.12.4.2 Germany: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.13 Spain
      • 10.2.2.14 Overview
        • 10.2.2.14.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.14.2 Spain: Malaria Treatment Market, by Treatment
        • 10.2.2.14.3 Spain: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.14.4 Spain: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.14.4.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.14.4.2 Spain: Malaria Treatment Market, by Retail Pharmacies
      • 10.2.2.15 Rest of Europe
      • 10.2.2.16 Overview
        • 10.2.2.16.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.2.2.16.2 Rest of Europe: Malaria Treatment Market, by Treatment
        • 10.2.2.16.3 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.2.2.16.4 Rest of Europe: Malaria Treatment Market, by Distribution Channel
        • 10.2.2.16.4.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
        • 10.2.2.16.4.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
  • 10.3 Asia Pacific Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.3.1 Overview
    • 10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.3.2.1 Asia Pacific: Malaria Treatment Market, by Treatment
      • 10.3.2.2 Asia Pacific: Malaria Treatment Market, by Route of Administration
      • 10.3.2.3 Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.3.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.3.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.4 Asia Pacific: Malaria Treatment Market, by Countries
      • 10.3.2.5 Japan
      • 10.3.2.6 Overview
        • 10.3.2.6.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.6.2 Japan: Malaria Treatment Market, by Treatment
        • 10.3.2.6.3 Japan: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.6.4 Japan: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.6.4.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.6.4.2 Japan: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.7 India
      • 10.3.2.8 Overview
        • 10.3.2.8.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.8.2 India: Malaria Treatment Market, by Treatment
        • 10.3.2.8.3 India: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.8.4 India: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.8.4.1 India: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.8.4.2 India: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.9 South Korea
      • 10.3.2.10 Overview
        • 10.3.2.10.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.10.2 South Korea: Malaria Treatment Market, by Treatment
        • 10.3.2.10.3 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.10.4 South Korea: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.10.4.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.10.4.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.11 Australia
      • 10.3.2.12 Overview
        • 10.3.2.12.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.12.2 Australia: Malaria Treatment Market, by Treatment
        • 10.3.2.12.3 Australia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.12.4 Australia: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.12.4.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.12.4.2 Australia: Malaria Treatment Market, by Retail Pharmacies
      • 10.3.2.13 Rest of Asia Pacific
      • 10.3.2.14 Overview
        • 10.3.2.14.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.3.2.14.2 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
        • 10.3.2.14.3 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.3.2.14.4 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
        • 10.3.2.14.4.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
        • 10.3.2.14.4.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
  • 10.4 Middle East & Africa Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.4.1 Overview
    • 10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.4.2.1 Middle East & Africa: Malaria Treatment Market, by Treatment
      • 10.4.2.2 Middle East & Africa: Malaria Treatment Market, by Route of Administration
      • 10.4.2.3 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.3.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.3.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.4 Middle East & Africa: Malaria Treatment Market, by Country
      • 10.4.2.5 Saudi Arabia
      • 10.4.2.6 Overview
        • 10.4.2.6.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.6.2 Saudi Arabia: Malaria Treatment Market, by Treatment
        • 10.4.2.6.3 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.6.4 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.6.4.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.6.4.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.7 UAE
      • 10.4.2.8 Overview
        • 10.4.2.8.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.8.2 UAE: Malaria Treatment Market, by Treatment
        • 10.4.2.8.3 UAE: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.8.4 UAE: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.8.4.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.8.4.2 UAE: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.9 South Africa
      • 10.4.2.10 Overview
        • 10.4.2.10.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.10.2 South Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.10.3 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.10.4 South Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.10.4.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.10.4.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.11 Kenya
      • 10.4.2.12 Overview
        • 10.4.2.12.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.12.2 Kenya: Malaria Treatment Market, by Treatment
        • 10.4.2.12.3 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.12.4 Kenya: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.12.4.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.12.4.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.13 Tanzania
      • 10.4.2.14 Overview
        • 10.4.2.14.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.14.2 Tanzania: Malaria Treatment Market, by Treatment
        • 10.4.2.14.3 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.14.4 Tanzania: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.14.4.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.14.4.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.15 Rwanda
      • 10.4.2.16 Overview
        • 10.4.2.16.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.16.2 Rwanda: Malaria Treatment Market, by Treatment
        • 10.4.2.16.3 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.16.4 Rwanda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.16.4.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.16.4.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.17 Nigeria
      • 10.4.2.18 Overview
        • 10.4.2.18.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.18.2 Nigeria: Malaria Treatment Market, by Treatment
        • 10.4.2.18.3 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.18.4 Nigeria: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.18.4.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.18.4.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.19 Ghana
      • 10.4.2.20 Overview
        • 10.4.2.20.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.20.2 Ghana: Malaria Treatment Market, by Treatment
        • 10.4.2.20.3 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.20.4 Ghana: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.20.4.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.20.4.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.21 Uganda
      • 10.4.2.22 Overview
        • 10.4.2.22.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.22.2 Uganda: Malaria Treatment Market, by Treatment
        • 10.4.2.22.3 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.22.4 Uganda: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.22.4.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.22.4.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.23 Angola
      • 10.4.2.24 Overview
        • 10.4.2.24.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.24.2 Angola: Malaria Treatment Market, by Treatment
        • 10.4.2.24.3 Angola: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.24.4 Angola: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.24.4.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.24.4.2 Angola: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.25 Cameroon
      • 10.4.2.26 Overview
        • 10.4.2.26.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.26.2 Cameroon: Malaria Treatment Market, by Treatment
        • 10.4.2.26.3 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.26.4 Cameroon: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.26.4.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.26.4.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.27 Senegal
      • 10.4.2.28 Overview
        • 10.4.2.28.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.28.2 Senegal: Malaria Treatment Market, by Treatment
        • 10.4.2.28.3 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.28.4 Senegal: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.28.4.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.28.4.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.29 Zambia
      • 10.4.2.30 Overview
        • 10.4.2.30.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.30.2 Zambia: Malaria Treatment Market, by Treatment
        • 10.4.2.30.3 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.30.4 Zambia: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.30.4.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.30.4.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
      • 10.4.2.31 Rest of Middle East & Africa
      • 10.4.2.32 Overview
        • 10.4.2.32.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.4.2.32.2 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
        • 10.4.2.32.3 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.4.2.32.4 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
        • 10.4.2.32.4.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
        • 10.4.2.32.4.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
  • 10.5 South & Central America Malaria Treatment Market, Revenue and Forecast To 2030
    • 10.5.1 Overview
    • 10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.5.2.1 South & Central America: Malaria Treatment Market, by Treatment
      • 10.5.2.2 South & Central America: Malaria Treatment Market, by Route of Administration
      • 10.5.2.3 South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.3.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.3.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.4 South & Central America: Malaria Treatment Market, by Countries
      • 10.5.2.5 Brazil
      • 10.5.2.6 Overview
        • 10.5.2.6.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.6.2 Brazil: Malaria Treatment Market, by Treatment
        • 10.5.2.6.3 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.6.4 Brazil: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.6.4.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.6.4.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
      • 10.5.2.7 Argentina
      • 10.5.2.8 Overview
      • 10.5.2.9 Rest of South & Central America
      • 10.5.2.10 Overview
        • 10.5.2.10.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.5.2.10.2 Rest of South & Central America: Malaria Treatment Market, by Treatment
        • 10.5.2.10.3 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
        • 10.5.2.10.4 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
        • 10.5.2.10.4.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
        • 10.5.2.10.4.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies

11. Malaria Treatment Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Malaria Treatment Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Cipla Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sun Pharmaceutical Industries Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sanofi SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 GSK Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pfizer Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Service
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 AdvaCare Pharma USA LLC
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 VLP Therapeutics LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Lupin Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

14. Appendix